LakePharma Symposium - 2019

LakePharma is pleased to organize its annual Symposium to bring together individuals and organizations in the biotech community to discuss the latest developments in biologics.

The 2019 symposium will cover topics such as the latest advances in cell and gene therapies. The conference is designed to benefit scientists currently working in the biopharmaceutical industry who want to improve their awareness of the latest advancements in next-generation therapeutics, as well as non-scientists who seek a better understanding of the processes, challenges, and opportunities in the industry.

In addition to formal presentations, the symposium will include special topic workshops, a poster session, and a happy hour for networking. 

Register for the symposium today >>


Thursday, October 10, 2019


South San Francisco Conference Center, 255 South Airport Boulevard, South San Francisco, CA 94080

Organizing Committee:

Hua Tu, Ph.D.                                  CEO, LakePharma, Inc.

Norman Garceau, Ph.D.                  VP, Technical Operations, LakePharma, Inc.

Brian Zabel, Ph.D.                           Senior Director, Discovery Immunology, LakePharma, Inc.




Alan Ashworth, Ph.D., FRS
President of Helen Diller Family Comprehensive Cancer Center at UCSF

Michael Boychyn, Ph.D.
Vice President of Process
Development at REGENXBIO Inc.

Dean Felsher, MD, Ph.D.
Director of Oncology Research, 
Director of Translational Research
and Applied Medicine at Stanford

Everett Meyer, MD, Ph.D.
Medical and Scientific Director,
Cellular Therapy Facility
at Stanford University

Madhusudan Peshwa, Ph.D.
Chief Technology Officer of Global Cell
Therapy at GE Healthcare

David Schaffer, Ph.D.
Co- Founder & CSO of 4D Molecular
Director of the Berkeley
Stem Cell Center at UC Berkeley

Hua Tu, Ph.D.
President and CEO of LakePharma


       Pam Contag Ph.D.
          CEO, Bioeclipse


8:30 am -  5:30 pm, Thursday October 10, 2019

Four parallel lunch workshops - more information coming soon.


Preliminary Agenda:

Directed Evolution of Novel Adeno-Associated Viral Vectors for Clinical Gene Therapy, David Schaffer, Ph.D., 4D Molecular Therapeutics


A Platform for Identifying Strategies for Reversing Cancer and Restoring the Immune Response, Dean Felsher, MD, Ph.D., Stanford University


Comparison of Baculovirus (BV)-Sf9 and HEK293 Expression Systems for the Production of Adeno-Associated Virus (AAV) Vectors, Michael Boychyn, Ph.D., REGENXBIO


More sessions will be announced soon.




Now accepting exhibitor applications and poster submissions.

Please contact for more information.

Attendee registration opening is now open. Register >>

Get directions to the conference center

  • Parking is available at the conference center and additional parking is permitted in the lots at the adjacent Holiday Inn.
  • CalTrain shuttle service to the Conference Center is provided from the South San Francisco CalTrain station every 30 minutes during commute hours (until 9:43 am)